Workflow
福建广生堂药业股份有限公司关于2025年第二次临时股东大会决议的公告

Meeting Details - The second extraordinary general meeting of shareholders for 2025 was held on September 17, 2025, at 14:30 [2] - The meeting combined on-site voting and online voting, with specific time slots for online voting [3][4] Attendance - A total of 417 shareholders attended the meeting, representing 66,288,792 shares, which is 41.6212% of the total shares [5] - Among them, 5 shareholders attended in person, representing 65,131,292 shares (40.8944%), while 412 shareholders participated via online voting, representing 1,157,500 shares (0.7268%) [5][6] Resolutions - The meeting approved the proposal regarding the equity transfer and capital increase of a controlling subsidiary, with 66,098,092 shares in favor (99.7123%) [8] - The minority shareholders voted 966,800 shares in favor (83.5248%) of the same proposal [9] Legal Opinion - The legal representatives from Guohao Law Firm confirmed that the meeting's procedures complied with relevant laws and regulations, and the voting results were valid [11] Documentation - The resolutions from the second extraordinary general meeting and the legal opinion from Guohao Law Firm are available for review [12]